Synthena AG
6Patents
6Active
6Granted
44Portfolio score
Filing activity: Sep 10, 2014 → Aug 3, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10059947B2 | Nucleic acids and methods for the treatment of Pompe disease | Chemistry; Metallurgy | 2 | Active |
| US11104903B2 | Nucleic acids and methods for the treatment of Pompe disease | Chemistry; Metallurgy | 1 | Active |
| US12319667B2 | Tricyclo-DNA nucleoside precursors and processes for preparing the same | Chemistry; Metallurgy | 0 | Active |
| US11118179B2 | Mixed tricyclo-DNA, 2′-modified RNA oligonucleotide compositions and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11872239B2 | Modified oligomeric compounds comprising tricyclo-DNA nucleosides and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12091665B2 | Nucleic acids and methods for the treatment of Pompe disease | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.